3 Small Cap Supported by heavy traffic, ready for takeoffPosted by Editor on 1/27/11 • Categorized as Penny Stocks YRC Worldwide Inc. (NASDAQ: YRCW) will announce its fourth quarter 2010 financial results February 4, 2011. Last month, YRC Worldwide has announced changes to its credit agreement and ease of asset-backed securitization. The changes are designed to provide more time for the company and its key stakeholders to develop plans to recapitalize its balance sheet. YRC shares are rising on the market today, fueled by positive estimates that the trucking industry may be on the road to recovery. At last report, the stock of small capitalization has increased from 3.30% to $ 4.38, increasing the average daily volume of 1.79 to 4,640,000. YRC Worldwide is an Overland Park, Kansas holding company providing a variety of transportation services through its subsidiaries. Shares of American Power Corp. (OTC: Department of Public Works) rally on the market today. The penny stock hit a 52-week high of $ 1.92 in midday trading, and at last check, is up 9.14% at $ 1.91, increasing the average daily volume of 861,323 to 4,290,000. penny stock of American power has a duration of 52 weeks at $ 0.61, $ 1.92. Over the last three sessions, the title won 40.44%. Last month, American Power gave an update on its financing activities during 2010. The company said that in September 2010, has closed a financing agreement for gross proceeds of $ 10 million through a stock issuance agreement of 2.5 years. The company has signed the financing agreement with a European institutional investor. Power Company is an American, Denver Colorado, Energy. MultiCell Technologies Shares (OTC: MCET) attending a sharp fall in trading today. The penny stock trading was 28.57% lower than $ 0.0100, at the time of last check, with a higher than average daily volume of 12.52 million to 65.72 million. Despite the loss today, the shares gained 28.21% over the last three sessions MultiCell. In November of last year, announced the receipt of qualifying cash grant under MultiCell U. S. Government Project Discovery program of therapy. MultiCell is a clinical stage biopharmaceutical company, focusing on development of new treatments and discovery tools to meet the medical needs for the treatment of unmet medical need. http://dailyinsider.net/2011/01/27/...eavy-traffic-ready-for-takeoff/ |